Machine Learning

FeatherSnap heads to CES 2026 with its AI bird feeders, highlighting the smart home's expansion into nature, citizen science, and a competitive market.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

All eyes are on Sandisk's Jan 29 report. Can the reborn flash memory leader meet lofty expectations and prove its post-spin-off strategy is a success?

Cannabix Technologies lands its first international order for its smart breathalyzer in Australia, a move that validates its tech and reshapes its finances.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Esports giant OverActive Media is raising fresh capital. Is this a strategic push into AI and esports dominance or a necessary move to shore up its finances?

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

The Emberly at Heritage Glen opens, combining advanced AI care monitoring with a people-first philosophy to meet Fort Worth’s growing senior care needs.

HII delivers the advanced Ted Stevens (DDG 128), a Flight III destroyer with game-changing radar, bolstering U.S. naval power amid industrial challenges.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

The robotics firm is outsourcing key software development in a strategic move to reduce cash burn and speed its innovative surgical system to market.

The med-tech firm has submitted its AI-assisted capsule endoscopy module to the FDA, promising faster, more accurate, and accessible GI disease detection.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?

Millions miss their IELTS goals by a tiny margin. A new wave of AI tools promises instant feedback to help save dreams, deadlines, and thousands of dollars.